Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Adverse Event
100%
Quality of Life
69%
Radiation Dermatitis
62%
Immunotherapy
54%
Cancer
49%
Malignant Neoplasm
39%
Dermatology
34%
Head and Neck Cancer
34%
Nail
34%
Melanoma
31%
Acral Lentiginous Melanoma
31%
Dermatological Agent
29%
Dermatitis
25%
Physical Examination
23%
Targeted Therapy
22%
Systematic Review
22%
Cancer Therapy
21%
Erythema
21%
Paronychia
21%
Cancer Treatment
20%
Povidone Iodine
20%
Immune Checkpoint Inhibitor
19%
Randomized Controlled Trial
19%
Vasculitis
18%
Hand Foot Syndrome
17%
Hyperpigmentation
17%
Arm
17%
Disease Exacerbation
17%
Patient Referral
17%
Axitinib
16%
Staphylococcus Aureus
16%
Clinician
15%
National Lung Screening Trial
15%
Skin Carcinoma
15%
Ultraviolet Irradiation
15%
Desmoplastic Melanoma
15%
Nummular Dermatitis
15%
Amyloidosis
15%
Bleomycin
15%
Halo Nevus
15%
Melanocyte
15%
Livedo reticularis
15%
Reducing Agent
15%
Adipocyte
15%
Total Knee Arthroplasty
15%
Dermatitis Herpetiformis
15%
Hair Disease
15%
Case-Control Study
15%
Deoxycholic Acid
15%
Drug Therapy
15%
Keyphrases
Anticancer Therapy
31%
Cutaneous Toxicity
31%
Narrative Review
31%
Acral Melanoma
31%
Acral Lentiginous Melanoma
31%
Skin Color
31%
Dermatologist
23%
Multikinase Inhibitor
19%
Axitinib
17%
National Lung Screening Trial
15%
Bibliometric Analysis
15%
Nummular Eczema
15%
Predictive Biomarker
15%
Desmoplastic Melanoma
15%
Bacterial Decolonization
15%
Primary Cutaneous Amyloidosis
15%
Cutaneous Malignancy
15%
Price Change
15%
Referral Practices
15%
Wholesale Price
15%
Medical Coding
15%
Medical Billing
15%
Halo Nevus
15%
Livedo Reticularis
15%
Anti-PD-1
15%
Flagellate Erythema
15%
Radiation Dermatitis
15%
Multidisciplinary Approach
15%
Disease Survival
15%
Postsurgical
15%
Febrile Ulceronecrotic Mucha-Habermann Disease
15%
Total Knee Arthroplasty
15%
Sorafenib
15%
Clinical Outcomes
15%
Disease Progression
15%
You Know
15%
Dermatitis Herpetiformis
15%
Cutaneous Immune-related Adverse Events
15%
Metastatic Melanoma
15%
Epicutaneous Immunotherapy
15%
Psychosocial Therapy
15%
USCOM
15%
Immunotherapy-related Adverse Events
15%
Oncodermatology
15%
Hydroxycholoroquine
15%
Sunitinib
15%
Disease Pattern
15%
Nivolumab
15%
Tivozanib
15%
Immune Checkpoint Inhibitor Therapy
15%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
65%
Adverse Event
36%
Radiation Dermatitis
31%
Skin Toxicity
31%
Immunotherapy
23%
Randomized Controlled Trial
19%
Dermatological Agent
19%
Paronychia
18%
Symptom
16%
Side Effect
16%
Metastatic Melanoma
15%
Biological Marker
15%
Estrogen Receptor
15%
Sleep Disordered Breathing
15%
Soybean
15%
Sorafenib
15%
Clinical Study
15%
Sunitinib
15%
Povidone-Iodine
15%
Hand Foot Syndrome
15%
Lung Cancer
15%
Estrogen Deficiency
15%
Hyperpigmentation
15%
Dermatitis Herpetiformis
15%
Wound Healing
15%
Disease Exacerbation
15%
Menopausal Syndrome
15%
Hormone Cancer Therapy
13%
Monotherapy
12%
Skin Manifestation
11%
CD8 Antigen
9%
Epidermal Growth Factor Receptor
9%
Overall Survival
9%
Pruritus
8%
Disease Free Survival
7%
Tolerability
7%
Chemotherapy Agent
7%
Survival Rate
7%
Disease
7%
Sleep Medicine
6%
Chemotherapy
6%
Non Small Cell Lung Cancer
6%
Breast Cancer
6%
Desquamation
5%
Syndrome
5%
Hydroxychloroquine
5%
Systemic Lupus Erythematosus
5%
